Runben Biotechnology Co., Ltd. (SHA:603193)
China flag China · Delayed Price · Currency is CNY
26.13
-0.03 (-0.11%)
Apr 29, 2026, 3:00 PM CST

Runben Biotechnology Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 2020 - 2019
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 2020 - 2019
Cash & Equivalents
168.56185.77106.59243.83368.21206.19
Upgrade
Short-Term Investments
--77.951,340--
Upgrade
Trading Asset Securities
973.5990.171,249198.2456.24
Upgrade
Cash & Short-Term Investments
1,1421,1761,4341,603376.45262.43
Upgrade
Cash Growth
-17.61%-17.97%-10.57%325.85%43.45%221.20%
Upgrade
Accounts Receivable
22.1317.9113.594.821.192.34
Upgrade
Other Receivables
5.644.244.622.3269.8
Upgrade
Receivables
27.7822.1518.227.147.212.15
Upgrade
Inventory
187.23120.59118.5792.91102.7156.9
Upgrade
Other Current Assets
338.56321.3424.4313.1623.6812.89
Upgrade
Total Current Assets
1,6961,6401,5951,716510.04344.36
Upgrade
Property, Plant & Equipment
300.54295.88267.57260.42277.56207.67
Upgrade
Other Intangible Assets
86.887.3254.5418.7619.3619.88
Upgrade
Long-Term Deferred Tax Assets
54.5850.4344.2320.8214.85.66
Upgrade
Long-Term Deferred Charges
2.051.511.261.41--
Upgrade
Other Long-Term Assets
292.23262.61256.91.133.6568.77
Upgrade
Total Assets
2,4322,3382,2192,019825.42646.34
Upgrade
Accounts Payable
104.2261.1653.840.1536.9946.37
Upgrade
Accrued Expenses
10.8715.7232.1626.2124.4311.41
Upgrade
Current Portion of Long-Term Debt
1.061.42----
Upgrade
Current Portion of Leases
--1.371.952.512.4
Upgrade
Current Income Taxes Payable
22.3816.2326.2915.4718.285.29
Upgrade
Current Unearned Revenue
6.5111.3813.375.974.54.2
Upgrade
Other Current Liabilities
9.346.9710.215.369.895.84
Upgrade
Total Current Liabilities
154.39112.88137.1995.1296.675.52
Upgrade
Long-Term Leases
--1.422.045.397.91
Upgrade
Long-Term Unearned Revenue
3.613.780.010.010.271.13
Upgrade
Long-Term Deferred Tax Liabilities
0.210.130.270.440.570.14
Upgrade
Total Liabilities
158.21116.79138.8897.61102.8384.69
Upgrade
Common Stock
404.59404.59404.59404.59343.9343.9
Upgrade
Additional Paid-In Capital
1,0151,0151,0151,015102.59101.69
Upgrade
Retained Earnings
853.84801.2660.67502.12276.09116.05
Upgrade
Shareholders' Equity
2,2742,2212,0801,921722.59561.65
Upgrade
Total Liabilities & Equity
2,4322,3382,2192,019825.42646.34
Upgrade
Total Debt
1.061.422.7847.9110.31
Upgrade
Net Cash (Debt)
1,1411,1751,4311,599368.54252.12
Upgrade
Net Cash Growth
-17.54%-17.91%-10.52%333.90%46.18%208.59%
Upgrade
Net Cash Per Share
2.822.913.534.531.080.75
Upgrade
Filing Date Shares Outstanding
404.89403.52404.59404.59404.59343.9
Upgrade
Total Common Shares Outstanding
404.89403.52404.59404.59343.9343.9
Upgrade
Working Capital
1,5411,5271,4581,621413.44268.84
Upgrade
Book Value Per Share
5.625.505.144.752.101.63
Upgrade
Tangible Book Value
2,1872,1342,0261,903703.22541.76
Upgrade
Tangible Book Value Per Share
5.405.295.014.702.041.58
Upgrade
Buildings
--231.94232.54231.65163.47
Upgrade
Machinery
--96.787.7779.0657.22
Upgrade
Construction In Progress
--18.071.825.767.17
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.